Baxter International (BAX) Accumulated Expenses (2009 - 2026)

Baxter International (BAX) has 17 years of Accumulated Expenses data on file, last reported at $1.8 billion in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $1.8 billion, down 4.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 billion (down 4.9% YoY), and the FY2025 annual result was $2.0 billion, up 5.75% from the prior year.
• Accumulated Expenses declined to $1.8 billion in Q1 2026 per BAX's latest filing, from $2.0 billion in the prior quarter.
• Over five years, Accumulated Expenses peaked at $2.5 billion in Q3 2023 and troughed at $1.8 billion in Q1 2026.
• A 5-year average of $2.1 billion and a median of $2.2 billion in 2022 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2024: Accumulated Expenses advanced 28.51% in 2022, then sank 30.15% in 2024.
• A 5-year view of Accumulated Expenses shows it stood at $2.2 billion in 2022, then declined by 11.75% to $1.9 billion in 2023, then dropped by 2.82% to $1.9 billion in 2024, then climbed by 5.75% to $2.0 billion in 2025, then decreased by 10.32% to $1.8 billion in 2026.
• Business Quant data shows BAX's Accumulated Expenses at $1.8 billion in Q1 2026, $2.0 billion in Q4 2025, and $2.1 billion in Q3 2025.